Search

Last May, the Trump administration announced its “American Patients First” plan requiring pharmaceutical companies to reveal drug prices in their television ads. The administration described it as a “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” But a new study in JAMA Internal Medicine, co-authored by a Carey Business School faculty member, disputes the plan’s premise. The study found that price disclosure in ads may cut into demand for more costly drugs. However, price disclosure does not lead to reduced demand when ads include modifiers explaining that insurance coverage

The new Executive Certificate in Organizational Leadership is built upon principles and frameworks that empower individuals to effectively lead people and organizations through real-world problem solving.

Suzanne Rybczynski used her Carey MS in Health Care Management to transition from physician to associate chief medical officer. Her advice to aspiring medical leaders: “You miss 100% of the shots you don’t take.”

Carey MBA alum, Gracelyn McDermott, leads business development at Kaiser Permanente, one of the largest nonprofit health care plans in the U.S. She shares her takeaways from leading through COVID and the changing health care industry.

Valerie Suslow investigates antitrust allegations against some of the world’s largest suppliers of farm-raised salmon, and the role vertical relations and price indices may play.

A small, little-known Chinese tech company is forcing investors to rethink the economics of artificial intelligence. Bernard T. Ferrari Professor Tinglong Dai shares his insights.

Carey Business School researcher Vadim Elenev offers an alternative model that would have achieved similar results to those of the U.S. economic stimulus in response to the COVID-19 pandemic, but at a lower cost.

The impressive list of awards and publications that follow these new faculty members is certainly noteworthy. So are the things that motivate them. Meet four of our eleven new faculty.